Global Longlife Hospital & Research (BOM:543520) ROCE %: -3.22% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543520 Global Longlife Hospital & Research Ltd BOM:543520
36 GF Score
Price ₹13.04
GF Value ₹1.37
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Global Longlife Hospital & Research ROCE %?

Global Longlife Hospital & Research BOM:543520 -1.81% 36 ROCE % is -3.22% as of Mar. 2026. GuruFocus rates BOM:543520 with a GF Score™ of 36/100 and a GF Value™ of ₹1.37 (Significantly Overvalued). The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Global Longlife Hospital & Research's annualized ROCE % for the quarter that ended in Mar. 2026 was -3.22%.

Global Longlife Hospital & Research  (BOM:543520) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Global Longlife Hospital & Research ROCE % Related Terms

Global Longlife Hospital & Research ROCE % Historical Data

* Premium members only.

The historical data trend for Global Longlife Hospital & Research's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Longlife Hospital & Research ROCE % Chart

Global Longlife Hospital & Research Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial 30.88 6.86 -3.20 1.39 -3.91

Global Longlife Hospital & Research Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.28 9.81 -7.50 -4.53 -3.22
BOM:543520
36GF Score
Global Longlife Hospital & Research Ltd BOM:543520
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Global Longlife Hospital & Research ROCE % Calculation

Global Longlife Hospital & Research's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=-9.88/( ( (268.446 - 0.558) + (237.613 - 0.12) )/ 2 )
=-9.88/( (267.888+237.493)/ 2 )
=-9.88/252.6905
=-3.91 %

Global Longlife Hospital & Research's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=-7.918/( ( (254.788 - 0.134) + (237.613 - 0.12) )/ 2 )
=-7.918/( ( 254.654 + 237.493 )/ 2 )
=-7.918/246.0735
=-3.22 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -3.22% mean?
Global Longlife Hospital & Research (BOM:543520) has a ROCE % of -3.22% as of Mar. 2026.
Is Global Longlife Hospital & Research's ROCE % too high?
Global Longlife Hospital & Research's current ROCE % is -3.22%. Overall, Global Longlife Hospital & Research has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Global Longlife Hospital & Research's ROCE % compare to HCA and THC?
Global Longlife Hospital & Research's ROCE % of -3.22% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.52, based on 641 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Global Longlife Hospital & Research's current ROCE % is -3.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Longlife Hospital & Research stock overvalued right now?
Based on GuruFocus' analysis, Global Longlife Hospital & Research (BOM:543520) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1.37, compared to a current price of ₹13.04 — trading 851.8% above its estimated fair value. The current ROCE % is -3.22%. Global Longlife Hospital & Research's overall GF Score™ is 36/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Global Longlife Hospital & Research (BOM:543520), the current ROCE % is -3.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Global Longlife Hospital & Research (BOM:543520) Overvalued in 2026?

Based on GuruFocus' analysis, Global Longlife Hospital & Research stock appears to be overvalued. The current stock price of ₹13.04 is trading 851.8% above its estimated GF Value™ of ₹1.37. GuruFocus considers Global Longlife Hospital & Research to be Significantly Overvalued.

Key valuation signals for BOM:543520:

  • ROCE %: -3.22%
  • GF Value™: ₹1.37 vs. price of ₹13.04 (851.8% above fair value)
  • GF Score™: 36/100 with 1 warning sign

No single metric tells the full story. See the BOM:543520 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Global Longlife Hospital & Research Business Description

Address Sindhu Bhavan Road, Beside Taj Skyline, 703, Sankalp Square, 3B, Ahmedabad, GJ, IND, 380 059
Global Longlife Hospital & Research Ltd is Multispecialty Hospital providing Medical & Allied Services. The company operates in the single segment i.e. Health Care and Hospital. Its services are Medical, Surgical, Radiology, Pathology, and Other Services.
36GF Score

Get the complete analysis for BOM:543520

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹13.04
Price
₹1.37
GF Value